These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 24723264)

  • 1. Harnessing neurogenesis for the possible treatment of Parkinson's disease.
    Lamm O; Ganz J; Melamed E; Offen D
    J Comp Neurol; 2014 Aug; 522(12):2817-30. PubMed ID: 24723264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.
    Park HJ; Shin JY; Lee BR; Kim HO; Lee PH
    Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.
    Fricke IB; Viel T; Worlitzer MM; Collmann FM; Vrachimis A; Faust A; Wachsmuth L; Faber C; Dollé F; Kuhlmann MT; Schäfers K; Hermann S; Schwamborn JC; Jacobs AH
    Eur J Neurosci; 2016 May; 43(10):1352-65. PubMed ID: 26950181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resident adult neural stem cells in Parkinson's disease--the brain's own repair system?
    van den Berge SA; van Strien ME; Hol EM
    Eur J Pharmacol; 2013 Nov; 719(1-3):117-127. PubMed ID: 23872414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain.
    van den Berge SA; van Strien ME; Korecka JA; Dijkstra AA; Sluijs JA; Kooijman L; Eggers R; De Filippis L; Vescovi AL; Verhaagen J; van de Berg WD; Hol EM
    Brain; 2011 Nov; 134(Pt 11):3249-63. PubMed ID: 22075520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson's disease.
    Schwerk A; Altschüler J; Roch M; Gossen M; Winter C; Berg J; Kurtz A; Akyüz L; Steiner B
    Regen Med; 2015 May; 10(4):431-46. PubMed ID: 26022763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenesis in substantia nigra of parkinsonian brains?
    Arias-Carrión O; Yamada E; Freundlieb N; Djufri M; Maurer L; Hermanns G; Ipach B; Chiu WH; Steiner C; Oertel WH; Höglinger GU
    J Neural Transm Suppl; 2009; (73):279-85. PubMed ID: 20411786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn dopaminergic neurons are associated with the migration and differentiation of SVZ-derived neural progenitors in a 6-hydroxydopamin-injected mouse model.
    Xie MQ; Chen ZC; Zhang P; Huang HJ; Wang TT; Ding YQ; Qi SS; Zhang C; Chen SX; Zhou P; Shao CC; Liao M; Sun CY
    Neuroscience; 2017 Jun; 352():64-78. PubMed ID: 28385636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
    Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
    Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis.
    Farzanehfar P
    Neurochem Res; 2016 Dec; 41(12):3161-3170. PubMed ID: 27613619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nestin-positive/SOX2-negative cells mediate adult neurogenesis of nigral dopaminergic neurons in mice.
    Albright JE; Stojkovska I; Rahman AA; Brown CJ; Morrison BE
    Neurosci Lett; 2016 Feb; 615():50-4. PubMed ID: 26806039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning.
    Schwerk A; Altschüler J; Roch M; Gossen M; Winter C; Berg J; Kurtz A; Steiner B
    Cytotherapy; 2015 Feb; 17(2):199-214. PubMed ID: 25457280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of mouse models of Parkinson's disease.
    Bobela W; Zheng L; Schneider BL
    Curr Protoc Mouse Biol; 2014 Sep; 4(3):121-39. PubMed ID: 25723963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic factors for the treatment of Parkinson's disease.
    Sullivan AM; Toulouse A
    Cytokine Growth Factor Rev; 2011 Jun; 22(3):157-65. PubMed ID: 21689963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone.
    Baker SA; Baker KA; Hagg T
    Eur J Neurosci; 2004 Jul; 20(2):575-9. PubMed ID: 15233767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversing a model of Parkinson's disease with in situ converted nigral neurons.
    Qian H; Kang X; Hu J; Zhang D; Liang Z; Meng F; Zhang X; Xue Y; Maimon R; Dowdy SF; Devaraj NK; Zhou Z; Mobley WC; Cleveland DW; Fu XD
    Nature; 2020 Jun; 582(7813):550-556. PubMed ID: 32581380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.